犬类关节炎治疗市场规模、份额和成长分析（按关节炎类型、给药途径、治疗方法、最终用户、分销管道和地区划分）—产业预测（2026-2033 年）

全球犬类关节炎治疗市场规模预计在 2024 年达到 28.3 亿美元，从 2025 年的 29.7 亿美元成长到 2033 年的 43.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.8%。

全球犬类关节炎治疗市场正经历显着成长，主要受犬类骨关节炎盛行率上升（与老龄化、肥胖以及某些犬种等因素相关）的推动。饲主越来越重视宠物的行动和疼痛问题，尤其是在兽医服务和早期诊断水平较高的已开发地区，他们更重视带宠物就医。对包括单株抗体、非类固醇消炎剂(NSAIDs) 和再生医学在内的长期治疗方案的需求，正在塑造着市场的主要趋势。此外，远端医疗服务和线上兽医诊所的扩张也加速了市场渗透。宠物医疗保健和预防保健成本的不断上涨，促使动物用药品商持续加强研发投入和产品创新，进一步支撑了市场的强劲前景。

全球犬类关节炎治疗市场驱动因素

全球犬类关节炎治疗市场主要受营养学和兽医学进步的推动，这些进步使犬隻能够活得更长久、更健康。随着老年犬数量的增加，关节炎等老龄化相关疾病的盛行率也随之上升，推动了对健康维护支援和慢性病照护方案的需求。这种人口结构的变化是市场发展的关键驱动因素，促使人们持续投资于旨在促进长期关节健康的有效治疗方法和药物。由此产生的对老年犬的日益关注，为该领域的创新和发展创造了良好的环境。

全球犬类关节炎治疗市场限制因素

生技药品和再生疗法的高昂费用限制了宠物饲主，尤其是在中低收入地区，获得这些疗法的机会。遍远地区兽医专家的短缺进一步加剧了这项挑战，阻碍了这些先进疗法的及时诊断和治疗。因此，这些障碍不仅限制了再生疗法的普及，也阻碍了新兴市场宠物医疗保健体系的发展。由此，许多宠物饲主在寻求犬类关节炎的有效治疗方法时面临着许多困难，这影响了全球犬类关节炎治疗市场的整体成长潜力。

全球犬类关节炎治疗市场趋势

全球犬类关节炎治疗市场正显着转向生技药品和再生医学，尤其是单株抗体和干细胞疗法。这一趋势强调开发针对特定患者、可持续的解决方案，以提供长期疼痛缓解并最大限度地减少副作用。这些创新不仅满足了对标靶有效治疗方法日益增长的需求，也体现了兽医学领域更广泛的策略，即加强慢性病护理。随着市场的发展，治疗方法的进步正在加速，以满足患有关节炎的动物的需求，这反映了人们致力于提高其生活品质的决心。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析
• 用例

全球犬类关节炎治疗市场规模（依关节炎类型划分）及复合年增长率（2026-2033 年）

• 骨关节炎
• 骨软骨病
• 类风湿性关节炎
• 创伤性关节炎

全球犬类关节炎治疗市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 口服
• 肠外
• 其他的

全球犬类关节炎治疗市场规模（依治疗方法划分）及复合年增长率（2026-2033 年）

• 非类固醇消炎剂（NSAIDs）
• 阿片类药物
• 干细胞疗法
• 异体干细胞
• 自体干细胞

全球犬类关节炎治疗市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 专科诊所
• 其他的

全球犬类关节炎治疗市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 兽医医院和诊所
• 零售药房
• 网路药房
• 其他的

全球犬类关节炎治疗市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

  主要企业简介

  • Boehringer Ingelheim
  • Zoetis
  • Elanco
  • Decora Pharmaceuticals
  • Merck Animal Health
  • American Regent, Inc.
  • Bayer AG
  • Nutramax Laboratories Veterinary Sciences, Inc.
  • VetStem, Inc.
  • Virbac

结论与建议

Global Canine Arthritis Treatment Market size was valued at USD 2.83 Billion in 2024 and is poised to grow from USD 2.97 Billion in 2025 to USD 4.31 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global canine arthritis treatment market is witnessing significant growth, driven by the rising prevalence of osteoarthritis in dogs, often linked to factors like age, obesity, and specific breeds. Pet owners are increasingly prioritizing veterinary care for mobility and pain-related concerns, particularly in developed regions where access to veterinary services and early diagnosis has improved. The demand for long-term therapeutics, including monoclonal antibodies, NSAIDs, and regenerative medicine, is shaping key market trends. Additionally, the expansion of telehealth services and online veterinary pharmacies is accelerating market penetration. Continued investments in research, development, and product innovation by veterinary pharmaceutical companies further bolster a strong market outlook, underpinned by growing expenditures on pet healthcare and preventive treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Arthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Canine Arthritis Treatment Market Segments Analysis

Global Canine Arthritis Treatment Market is segmented by Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel and region. Based on Arthritis Type, the market is segmented into Osteoarthritis, Osteochondrosis, Rheumatoid arthritis and Traumatic arthritis. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on Treatment, the market is segmented into Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells and Autologous Stem Cells. Based on End-Users, the market is segmented into Hospitals, Speciality Clinics and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is significantly driven by advancements in nutrition and veterinary care that enable dogs to enjoy longer, healthier lives. As the population of aging dogs increases, so does the prevalence of age-related conditions like arthritis, leading to a heightened demand for wellness support and chronic care options. This demographic shift serves as a key factor in driving the market, prompting continuous investments in effective treatments and medications aimed at promoting long-term joint health. Consequently, the focus on older canines is fostering a robust environment for innovation and development within the sector.

Restraints in the Global Canine Arthritis Treatment Market

The elevated expenses associated with biologics and regenerative treatments restrict access for pet owners, particularly in low- and middle-income areas. This challenge is exacerbated by the scarcity of veterinary specialists in rural regions, which hinders timely diagnosis and management of these advanced therapies. Consequently, such obstacles not only limit the adoption of regenerative treatments but also stifle the advancement of pet healthcare systems in emerging markets. As a result, many pet owners face significant barriers in seeking effective solutions for canine arthritis, thereby impacting the overall growth potential of the global canine arthritis treatment market.

Market Trends of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is witnessing a notable shift towards biologic and regenerative therapies, particularly monoclonal antibodies and stem cell treatments. This trend emphasizes the development of patient-specific and sustainable solutions that offer prolonged pain relief while minimizing adverse effects. Such innovations not only align with the growing demand for targeted and effective therapies but also highlight a broader strategy within veterinary medicine focused on enhancing chronic care. As the market evolves, there is a clear inclination towards accelerating therapeutic advancements that cater to the needs of animals suffering from arthritis, reflecting a commitment to improving their quality of life.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Canine Arthritis Treatment Market Size by Arthritis Type & CAGR (2026-2033)

• Market Overview
• Osteoarthritis
• Osteochondrosis
• Rheumatoid arthritis
• Traumatic arthritis

Global Canine Arthritis Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Parenteral
• Others

Global Canine Arthritis Treatment Market Size by Treatment & CAGR (2026-2033)

• Market Overview
• Non-steroidal anti-inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

Global Canine Arthritis Treatment Market Size by End-Users & CAGR (2026-2033)

• Market Overview
• Hospitals
• Speciality Clinics
• Others

Global Canine Arthritis Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Others

Global Canine Arthritis Treatment Market Size & CAGR (2026-2033)

• North America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Decora Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Regent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories Veterinary Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetStem, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations